Trifluridine / Tipiracil
Common brands: Lonsurf, Avastin, Ondansetron, Neurontin, Gaba 300-Ezs
Top reporter: Taiho Pharmaceutical Co., Ltd.
Nucleoside Analog Antiviral [EPC]Nucleoside Metabolic Inhibitor [EPC]Vascular Endothelial Growth Factor Inhibitor [EPC]Opioid Agonist [EPC]Benzodiazepine [EPC]
10,494
Total Reports
5,148
Serious Reports
4,196
Death Reports
30
Reported Reactions
Death Report Ratio: High (39.98%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Trifluridine / Tipiracil.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | DEATH | 3,079 | |
| 2 | DISEASE PROGRESSION | 1,795 | |
| 3 | FATIGUE | 1,371 | |
| 4 | NAUSEA | 1,150 | |
| 5 | DIARRHOEA | 987 | |
| 6 | DECREASED APPETITE | 679 | |
| 7 | VOMITING | 617 | |
| 8 | ASTHENIA | 485 | |
| 9 | WHITE BLOOD CELL COUNT DECREASED | 482 | |
| 10 | DRUG INEFFECTIVE | 360 | |
| 11 | ANAEMIA | 352 | |
| 12 | WEIGHT DECREASED | 329 | |
| 13 | CONSTIPATION | 327 | |
| 14 | NEUTROPENIA | 322 | |
| 15 | DEHYDRATION | 320 | |
| 16 | OFF LABEL USE | 314 | |
| 17 | ABDOMINAL PAIN | 312 | |
| 18 | INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 306 | |
| 19 | PAIN | 264 | |
| 20 | MALAISE | 260 | |
| 21 | ABDOMINAL PAIN UPPER | 250 | |
| 22 | PYREXIA | 250 | |
| 23 | PLATELET COUNT DECREASED | 230 | |
| 24 | MALIGNANT NEOPLASM PROGRESSION | 227 | |
| 25 | DYSPNOEA | 215 | |
| 26 | HAEMOGLOBIN DECREASED | 182 | |
| 27 | ALOPECIA | 175 | |
| 28 | DIZZINESS | 174 | |
| 29 | CYTOPENIA | 173 | |
| 30 | URINARY TRACT INFECTION | 165 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.